Please login to the form below

Blog: The Future of Food Allergy? The Emergence of Targeted Allergy Treatments

Research Analyst Rachel Arthurs explores how public exposure to the complications of food allergy has affected attitudes toward treatment.

In recent years, there has been a noticeable shift in the increased public awareness of allergy-related complications both within the United Kingdom and globally. In 2010, Allergy UK estimated that at least 44% of British adults were currently suffering from at least one allergy, a statistic that only continues to rise steadily each year. In the United States, Statista reported that approximately 20% of American adults in 2017 were suffering from an allergy or food intolerance. The growing interest in allergy shown by the British public was further amplified by the widespread outrage in 2017, following an incident in which a teenage customer of a popular British sandwich chain experienced anaphylaxis as a direct result of inadequate allergen labelling. This is not an isolated incident, but a constant fear and source of anxiety for allergy sufferers all over the world.

Read the full blog here: https://bit.ly/2VCPwf0

2nd May 2019

Share

Tags

Company Details

Research Partnership

+44 (0)20 8069 5000

Contact Website

Address:
Chester House
Fulham Green
81-83 Fulham High Street
London
SW6 3JW
United Kingdom

Latest content on this profile

Live webinar from Singapore
Digital #marcomms: How to evaluate and optimise marketing activities impacted by COVID-19
Research Partnership
Webinar
Every voice counts in MedTech – Getting more with less via an innovative trade-off technique
Research Partnership
Guide
UX research
Research Partnership
Article: Why pharma must trust the science of behaviour

Research Partnership
Case study
Using qualitative conjoint to assess willingness-to-pay
Research Partnership
Consumer health specialist joins Research Partnership Inc
Global healthcare market research consultancy Research Partnership has appointed Jennifer Stewart as a Director in their US offices in Philadelphia.
Research Partnership